Axsome Therapeutics Statistics
NASDAQ: AXSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
170.08-2.89 (-1.67%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Axsome Therapeutics by the numbers
Axsome Therapeutics has a market capitalization of $8.91 billion based on 52.38M shares outstanding. With trailing EPS of $-3.68, Axsome Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.8% below its 50-day average and 15.1% below its 200-day average.
Average daily trading volume is 712.30K shares, or about $121.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AXSM valuation vs. peer median
| Metric | AXSM | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.91B | $8.60B | +4% |
| Forward P/E | 36.2 | 19.0 | +90% |
| Avg. volume | 712.30K | 1.94M | -63% |
Peer median across 8 companies: PTGX, CYTK, ARWR, TGTX, RDY, BMRN, SYRE, PRAX.
Valuation
- Market cap
- $8.91B
- Forward P/E
- 36.17
- Price / sales (latest FY)
- 13.95
- EPS (TTM)
- $-3.68
- Shares outstanding
- 52.38M
Price and trading
- Previous close
- 172.97
- Open
- 170.09
- Day range
- 166.21 – 172.28
- 52-week range
- 119.20 – 260.19
- 52-week change
- +43.27%
- 50-day moving average
- 204.48
- 200-day moving average
- 200.29
- Beta
- —
- Volume
- 1.07M
- Average volume
- 712.30K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 8.91B
- Forward Pe
- 36.17
- Eps
- -3.68
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 260.19
- Week52 Low
- 119.20
- Avg Volume
- 712.30K
- Shares Outstanding
- 52.38M
- Ma50
- 204.48
- Ma200
- 200.29
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -34.63%
- Pct From52w Low
- 42.68%